These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9500493)
1. Effects of LY-117018 HCl on bone remodeling and mineral density in the oophorectomized rat. Curiel MD; Calero JA; Guerrero R; Gala J; Gazapo R; de la Piedra C Am J Obstet Gynecol; 1998 Feb; 178(2):320-5. PubMed ID: 9500493 [TBL] [Abstract][Full Text] [Related]
2. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34). Sato M; Zeng GQ; Rowley E; Turner CH Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476 [TBL] [Abstract][Full Text] [Related]
3. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats. Bowman AR; Sass DA; Marshall I; Ma YF; Liang H; Jee WS; Epstein S J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum pyridinoline cross-linked carboxy-terminal telopeptides of type I collagen and osteocalcin in the study of the bone resorption rate in oophorectomized rats. Calero JA; De la Piedra C; Díaz Curiel M Miner Electrolyte Metab; 1998; 24(5):303-6. PubMed ID: 9705565 [TBL] [Abstract][Full Text] [Related]
5. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats. Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271 [TBL] [Abstract][Full Text] [Related]
6. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys. Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885 [TBL] [Abstract][Full Text] [Related]
7. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401 [TBL] [Abstract][Full Text] [Related]
8. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000 [TBL] [Abstract][Full Text] [Related]
9. The preventive and interventional effects of raloxifene analog (LY117018 HCL) on osteopenia in ovariectomized rats. Li X; Takahashi M; Kushida K; Inoue T J Bone Miner Res; 1998 Jun; 13(6):1005-10. PubMed ID: 9626632 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. Prestwood KM; Gunness M; Muchmore DB; Lu Y; Wong M; Raisz LG J Clin Endocrinol Metab; 2000 Jun; 85(6):2197-202. PubMed ID: 10852452 [TBL] [Abstract][Full Text] [Related]
11. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo. Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314 [TBL] [Abstract][Full Text] [Related]
12. Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats. Xu M; Dick IM; Day R; Randall D; Prince RL Am J Chin Med; 2003; 31(1):87-101. PubMed ID: 12723758 [TBL] [Abstract][Full Text] [Related]
13. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823 [TBL] [Abstract][Full Text] [Related]
14. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys. Lees C; Shen V; Brommage R Menopause; 2007; 14(1):97-105. PubMed ID: 17075430 [TBL] [Abstract][Full Text] [Related]
15. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism. Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811 [TBL] [Abstract][Full Text] [Related]
16. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats. Brzóska MM; Moniuszko-Jakoniuk J Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044 [TBL] [Abstract][Full Text] [Related]
17. Effects of the antiestrogen LY 117018 on the modulation by ethinyl estradiol of the metabolism of [1-14C]oleic acid by perfused livers from normal and ovariectomized rats. Weinstein I; Heimberg M Biochem Pharmacol; 1988 Jan; 37(2):319-26. PubMed ID: 3342088 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of the alkaline (ALP) and acid phosphatase (ACP) in the blood serum of rats during experimental postmenopausal osteoporosis]. Rahnama M; Swiatkowski W; Zareba S Rocz Panstw Zakl Hig; 2002; 53(3):283-91. PubMed ID: 12621884 [TBL] [Abstract][Full Text] [Related]
19. Raloxifene analog LY 117018 effects on central and peripheral beta-endorphin. Genazzani AR; Bernardi F; Stomati M; Rubino S; Giardina L; Luisi S; Monteleone P; Genazzani AD; Luisi M; Petraglia F Gynecol Endocrinol; 1999 Aug; 13(4):249-58. PubMed ID: 10533160 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G Menopause; 2005; 12(5):589-600. PubMed ID: 16145313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]